(VIANEWS) – Good morning! Another day of trading is almost starting and here’s today’s list of stocks that have had significant trading activity in the US premarket session.

The three most active and biggest winners today are Canaan, TherapeuticsMD, and Marathon.

Rank Financial Asset Price Premarket
Change
Updated (EST)
1 Canaan (CAN) 9.61 4.68% 2021-09-15 07:11:43
2 TherapeuticsMD (TXMD) 0.76 4.66% 2021-09-15 07:13:08
3 Marathon (MARA) 36.06 3.98% 2021-09-15 07:09:31
4 BeiGene (BGNE) 382.00 3.55% 2021-09-15 07:11:33
5 Riot Blockchain (RIOT) 29.72 3.05% 2021-09-15 07:12:46
6 Nikola (NKLA) 10.20 2.93% 2021-09-15 07:12:31
7 Xenetic Biosciences (XBIO) 2.46 2.5% 2021-09-15 07:13:18
8 Exact Sciences (EXAS) 99.40 2.41% 2021-09-15 07:08:16
9 PetroChina (PTR) 48.16 2.36% 2021-09-15 06:16:59
10 Arcelor Mittal (MT) 33.06 2.35% 2021-09-15 07:16:19

The three most active and biggest losers today are AMC, JD.com, and Fox Corporation.

Rank Financial Asset Price Premarket
Change
Updated (EST)
1 AMC (AMC) 45.59 -3.62% 2021-09-15 07:13:43
2 JD.com (JD) 75.65 -2.89% 2021-09-15 07:09:21
3 Fox Corporation (FOX) 32.03 -2.47% 2021-09-15 06:08:40
4 Smith & Nephew (SNN) 36.00 -2.33% 2021-09-15 07:16:56
5 Lennar Corporation (LEN) 96.31 -2.31% 2021-09-15 07:15:58
6 Zoetis (ZTS) 199.00 -2.24% 2021-09-15 07:17:39
7 Pinduoduo (PDD) 99.70 -2.04% 2021-09-15 07:12:36
8 Fresenius Medical Care AG (FMS) 35.73 -1.98% 2021-09-15 06:15:33
9 NetEase (NTES) 82.90 -1.92% 2021-09-15 06:09:53
10 Genmab (GMAB) 43.10 -1.62% 2021-09-15 07:12:06

Most Active Premarket Winners today

1. Canaan (CAN) – Premarket: 4.68%

NASDAQ Composite ended the session with Canaan jumping 5.88% to $9.18 on Wednesday, after two consecutive sessions in a row of gains. NASDAQ Composite slid 0.45% to $15,037.76, after five sequential sessions in a row of losses, on what was a somewhat bearish trend exchanging session today.

Volume

Today’s last reported volume for Canaan is 6808920, 0.62% above its average volume of 6766490.

Canaan’s last close was $9.52, 75.65% under its 52-week high of $39.10.

Canaan’s Revenue

Year-on-year quarterly revenue growth grew by 489.9%, now sitting on 782.19M for the twelve trailing months.

Canaan’s Stock Yearly Top and Bottom Value

Canaan’s stock is valued at $9.18 at 08:34 EST, way below its 52-week high of $39.10 and way above its 52-week low of $1.81.

Canaan’s Moving Average

Canaan’s value is above its 50-day moving average of $8.58 and way under its 200-day moving average of $12.30.

More news about Canaan.

2. TherapeuticsMD (TXMD) – Premarket: 4.66%

NASDAQ Composite ended the session with TherapeuticsMD falling 6.67% to $0.73 on Wednesday, following the last session’s downward trend. NASDAQ Composite slid 0.45% to $15,037.76, after five sequential sessions in a row of losses, on what was a somewhat bearish trend trading session today.

Volume

Today’s last reported volume for TherapeuticsMD is 8623860, 56% above its average volume of 5527780.

TherapeuticsMD’s last close was $0.80, 70.91% under its 52-week high of $2.75.

TherapeuticsMD’s Sales

TherapeuticsMD’s sales growth is 33.7% for the ongoing quarter and 29.3% for the next. The company’s growth estimates for the current quarter and the next is 16.7% and 40%, respectively.

TherapeuticsMD’s Revenue

Year-on-year quarterly revenue growth grew by 114.9%, now sitting on 84.79M for the twelve trailing months.

TherapeuticsMD’s Stock Yearly Top and Bottom Value

TherapeuticsMD’s stock is valued at $0.73 at 08:34 EST, way under its 52-week high of $2.75 and above its 52-week low of $0.72.

TherapeuticsMD’s Moving Average

TherapeuticsMD’s worth is way under its 50-day moving average of $0.87 and way below its 200-day moving average of $1.15.

More news about TherapeuticsMD.

3. Marathon (MARA) – Premarket: 3.98%

NASDAQ Composite ended the session with Marathon falling 2.56% to $34.68 on Wednesday while NASDAQ Composite slid 0.45% to $15,037.76.

Volume

Today’s last reported volume for Marathon is 7300320, 24.6% below its average volume of 9682790.

Marathon’s last close was $43.41, 24.83% under its 52-week high of $57.75.

Marathon’s Revenue

Year-on-year quarterly revenue growth grew by 1444.8%, now sitting on 12.92M for the twelve trailing months.

Marathon’s Stock Yearly Top and Bottom Value

Marathon’s stock is valued at $34.68 at 08:34 EST, way below its 52-week high of $57.75 and way above its 52-week low of $1.48.

Marathon’s Moving Average

Marathon’s worth is higher than its 50-day moving average of $34.55 and higher than its 200-day moving average of $32.89.

Previous days news about Marathon

  • Vienna marathon winner disqualified for wearing banned shoes. According to Bloomberg Quint on Sunday, 12 September, "Derara Hurisa crossed the line in the Vienna City Marathon in 2:09:22 on a warm early autumn morning, beating Kenyan Leonard Langat by three seconds."
  • Pete najarian sees unusual options activity in AMD and marathon oil. According to Benzinga on Tuesday, 14 September, "On CNBC’s "Fast Money Halftime Report," Pete Najarian spoke about unusually high options activity in Advanced Micro Devices, Inc. (NASDAQ: AMD) and Marathon Oil Corporation (NYSE: MRO) on Tuesday.", "Almost 4,000 contracts of the September $11.50 calls were traded in Marathon Oil for about 40 cents. "

More news about Marathon.

4. BeiGene (BGNE) – Premarket: 3.55%

NASDAQ Composite ended the session with BeiGene rising 1.28% to $368.89 on Wednesday, after five successive sessions in a row of gains. NASDAQ Composite fell 0.45% to $15,037.76, after five consecutive sessions in a row of losses, on what was a somewhat bearish trend exchanging session today.

Volume

Today’s last reported volume for BeiGene is 397146, 23.37% above its average volume of 321900.

BeiGene’s last close was $336.32, 13.54% below its 52-week high of $388.97.

BeiGene’s Sales

BeiGene’s sales growth is 188.9% for the current quarter and 161.6% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 19.3% and a negative 0.4%, respectively.

BeiGene’s Revenue

Year-on-year quarterly revenue growth grew by 1063.8%, now sitting on 862.69M for the twelve trailing months.

BeiGene’s Stock Yearly Top and Bottom Value

BeiGene’s stock is valued at $368.89 at 08:34 EST, below its 52-week high of $388.97 and way higher than its 52-week low of $219.20.

BeiGene’s Moving Average

BeiGene’s worth is way higher than its 50-day moving average of $307.83 and way above its 200-day moving average of $323.04.

Previous days news about BeiGene

  • Beigene : FDA accepts BLA for tislelizumab in esophageal squamous cell carcinoma. According to Business Insider on Monday, 13 September, "The accepted BLA, filed in collaboration with Novartis, is supported by the positive global Phase 3 RATIONALE 302 trial in patients with previously treated, advanced or metastatic ESCC and safety data from tislelizumab’s broad clinical program, BeiGene said in a statement."

More news about BeiGene.

5. Riot Blockchain (RIOT) – Premarket: 3.05%

NASDAQ Composite ended the session with Riot Blockchain sliding 1.57% to $28.84 on Wednesday, after five successive sessions in a row of losses. NASDAQ Composite dropped 0.45% to $15,037.76, after five consecutive sessions in a row of losses, on what was a somewhat bearish trend trading session today.

Volume

Today’s last reported volume for Riot Blockchain is 7402900, 28.08% below its average volume of 10293600.

Riot Blockchain’s last close was $34.43, 56.69% under its 52-week high of $79.50.

The company’s growth estimates for the present quarter and the next is 700% and 125%, respectively.

Riot Blockchain’s Revenue

Year-on-year quarterly revenue growth grew by 1668.7%, now sitting on 65.3M for the twelve trailing months.

Riot Blockchain’s Stock Yearly Top and Bottom Value

Riot Blockchain’s stock is valued at $28.84 at 08:34 EST, way below its 52-week high of $79.50 and way higher than its 52-week low of $2.35.

Riot Blockchain’s Moving Average

Riot Blockchain’s worth is way below its 50-day moving average of $34.40 and way under its 200-day moving average of $37.76.

More news about Riot Blockchain.

6. Nikola (NKLA) – Premarket: 2.93%

NASDAQ Composite ended the session with Nikola falling 1.2% to $9.91 on Wednesday while NASDAQ Composite dropped 0.45% to $15,037.76.

Volume

Today’s last reported volume for Nikola is 8734980, 27.46% below its average volume of 12041800.

Nikola’s last close was $10.46, 72.44% under its 52-week high of $37.95.

News about Nikola today

  • Nikola showcases German plant nearing first production of electric trucks. According to today’s article on Bloomberg Quint, "In addition to unveiling their joint-venture facility on Wednesday, Iveco and Nikola announced an agreement with the Hamburg Port Authority to test up to 25 battery-electric Tre trucks starting next year.", "Russell followed Milton to Nikola from metals manufacturer Worthington Industries Inc., which acquired one of Milton’s earlier business ventures. "

The company’s growth estimates for the current quarter and the next is a negative 75% and a negative 76.5%, respectively.

Nikola’s Stock Yearly Top and Bottom Value

Nikola’s stock is valued at $9.91 at 08:34 EST, way below its 52-week high of $37.95 and higher than its 52-week low of $9.02.

Nikola’s Moving Average

Nikola’s value is under its 50-day moving average of $10.53 and way below its 200-day moving average of $13.46.

More news about Nikola.

7. Xenetic Biosciences (XBIO) – Premarket: 2.5%

NASDAQ Composite ended the session with Xenetic Biosciences falling 4.76% to $2.40 on Wednesday, after five consecutive sessions in a row of losses. NASDAQ Composite slid 0.45% to $15,037.76, after five sequential sessions in a row of losses, on what was a somewhat bearish trend trading session today.

Volume

Today’s last reported volume for Xenetic Biosciences is 346288, 96.59% below its average volume of 10160900.

Xenetic Biosciences’s last close was $2.71, 53.68% below its 52-week high of $5.85.

Xenetic Biosciences’s Sales

Xenetic Biosciences’s sales growth is 72.4% for the current quarter and a decline by 33.8% for the next. The company’s growth estimates for the ongoing quarter and the next is 90% and 6.3%, respectively.

Xenetic Biosciences’s Revenue

Year-on-year quarterly revenue growth grew by 786.7%, now sitting on 436.94k for the twelve trailing months.

Xenetic Biosciences’s Stock Yearly Top and Bottom Value

Xenetic Biosciences’s stock is valued at $2.40 at 08:34 EST, way below its 52-week high of $5.85 and way above its 52-week low of $0.76.

Xenetic Biosciences’s Moving Average

Xenetic Biosciences’s worth is way under its 50-day moving average of $3.27 and above its 200-day moving average of $2.39.

More news about Xenetic Biosciences.

8. Exact Sciences (EXAS) – Premarket: 2.41%

NASDAQ Composite ended the session with Exact Sciences falling 2.63% to $97.06 on Wednesday, following the last session’s downward trend. NASDAQ Composite fell 0.45% to $15,037.76, after five sequential sessions in a row of losses, on what was a somewhat down trend exchanging session today.

Volume

Today’s last reported volume for Exact Sciences is 857382, 33.91% below its average volume of 1297350.

Exact Sciences’s last close was $107.98, 32.32% under its 52-week high of $159.54.

Exact Sciences’s Sales

Exact Sciences’s sales growth is 27.6% for the present quarter and a decline by 1% for the next. The company’s growth estimates for the present quarter and the next is 41.8% and 67%, respectively.

Exact Sciences’s Revenue

Year-on-year quarterly revenue growth grew by 15.6%, now sitting on 1.55B for the twelve trailing months.

Exact Sciences’s Stock Yearly Top and Bottom Value

Exact Sciences’s stock is valued at $97.06 at 08:34 EST, way below its 52-week high of $159.54 and way higher than its 52-week low of $70.75.

Exact Sciences’s Moving Average

Exact Sciences’s worth is below its 50-day moving average of $102.48 and way under its 200-day moving average of $116.42.

More news about Exact Sciences.

9. PetroChina (PTR) – Premarket: 2.36%

NYSE Composite ended the session with PetroChina rising 1.38% to $47.05 on Wednesday, after five sequential sessions in a row of gains. NYSE Composite dropped 0.42% to $16,731.05, after five successive sessions in a row of losses, on what was a somewhat down trend exchanging session today.

Volume

Today’s last reported volume for PetroChina is 352615, 39.25% above its average volume of 253210.

PetroChina’s last close was $45.54, 10.99% under its 52-week high of $51.16.

PetroChina’s Revenue

Year-on-year quarterly revenue growth grew by 8.4%, now sitting on 1.98T for the twelve trailing months.

PetroChina’s Stock Yearly Top and Bottom Value

PetroChina’s stock is valued at $47.05 at 08:34 EST, below its 52-week high of $51.16 and way above its 52-week low of $27.68.

PetroChina’s Moving Average

PetroChina’s value is way higher than its 50-day moving average of $42.22 and way higher than its 200-day moving average of $40.98.

More news about PetroChina.

10. Arcelor Mittal (MT) – Premarket: 2.35%

NYSE Composite ended the session with Arcelor Mittal sliding 2.12% to $32.30 on Wednesday, after two consecutive sessions in a row of losses. NYSE Composite dropped 0.42% to $16,731.05, after five consecutive sessions in a row of losses, on what was a somewhat bearish trend trading session today.

Volume

Today’s last reported volume for Arcelor Mittal is 2256070, 39.14% below its average volume of 3707180.

Arcelor Mittal’s last close was $33.60, 8.15% under its 52-week high of $36.58.

Arcelor Mittal’s Sales

Arcelor Mittal’s sales growth is 64.7% for the current quarter and 47.1% for the next. The company’s growth estimates for the ongoing quarter and the next is 2536.8% and 1826.3%, respectively.

Arcelor Mittal’s Revenue

Year-on-year quarterly revenue growth grew by 76.2%, now sitting on 62.99B for the twelve trailing months.

Arcelor Mittal’s Stock Yearly Top and Bottom Value

Arcelor Mittal’s stock is valued at $32.30 at 08:34 EST, way below its 52-week high of $36.58 and way higher than its 52-week low of $11.84.

Arcelor Mittal’s Moving Average

Arcelor Mittal’s worth is below its 50-day moving average of $34.30 and above its 200-day moving average of $30.93.

More news about Arcelor Mittal.

Most Active Premarket Losers Today

1. AMC (AMC) – Premarket: -3.62%

NYSE Composite ended the session with AMC sliding 8.49% to $47.30 on Wednesday while NYSE Composite dropped 0.42% to $16,731.05.

Volume

Today’s last reported volume for AMC is 65158700, 39.67% below its average volume of 108010000.

AMC’s last close was $44.02, 39.38% under its 52-week high of $72.62.

News about AMC today

  • Ironnet, Apple, gamestop, amc, clover health: stocks on wallstreetbets radar today. According to today’s article on Benzinga, "IronNet Cybersecurity Inc. (NYSE:IRNT), Apple Inc. (NASDAQ:AAPL), GameStop Corp. (NYSE:GME), AMC Entertainment Holdings Inc. (NYSE:AMC) and Clover Health Investments Corp. (NASDAQ:CLOV) are among the stocks seeing the highest interest on Reddit’s r/WallStreetBets forum as of Tuesday night.", "Apart from videogame retailer GameStop, movie theatre chain AMC Entertainment and Medicare Advantage insurer Clover Health, the other stocks trending on the forum include FuelCell Energy Inc. (NASDAQ:FCEL), TMC the metals company Inc. (NASDAQ:TMC) and electric vehicle maker Tesla Inc. (NASDAQ:TSLA)."
  • AMC stock price and news: shares of AMC tumble as meme rally is cut short. According to today’s article on FXStreet, "On Tuesday, shares of AMC fell by 8.49% to close the volatile trading session at $47.30. ", "Despite the movie theater industry on a downward trend for the past few years, AMC apes still fully believe in the future of the company. "
  • AMC entertainment holdings (amc) stock price and forecast: why the fall?. According to today’s article on FXStreet, "There was talk of a negative report out on the stock from some investing websites, but AMC traders are well used to analysts calling the stock lower and ignore this and focus on momentum, so we do not give that excuse much credence. ", "The AMC 15 minute chart above shows Tuesday’s session was weak throughout with little in the way of a bounce. "

The company’s growth estimates for the ongoing quarter and the next is 93.6% and 96.6%, respectively.

AMC’s Revenue

Year-on-year quarterly revenue growth declined by 84.2%, now sitting on 449.2M for the twelve trailing months.

AMC’s Stock Yearly Top and Bottom Value

AMC’s stock is valued at $47.30 at 08:34 EST, way below its 52-week high of $72.62 and way above its 52-week low of $1.91.

AMC’s Moving Average

AMC’s value is way higher than its 50-day moving average of $38.85 and way above its 200-day moving average of $28.61.

Previous days news about AMC

  • Cameco, gamestop, amc, tmc, clover health and more: stocks buzzing on wallstreetbets today. According to Benzinga on Tuesday, 14 September, "Cameco Corp. (NYSE:CCJ), GameStop Corp. (NYSE:GME), AMC Entertainment Holdings Inc. (NYSE:AMC), TMC the metals company Inc. (NASDAQ:TMC) and Clover Health Insurance Corp. (NASDAQ:CLOV) are among the stocks seeing the highest interest on Reddit’s r/WallStreetBets forum as of early Tuesday.", "Apart from movie theatre chain AMC Entertainment, mining startup TMC the metals company and Medicare Advantage insurer Clover Health, the other stocks trending on the forum include tech giant Apple Inc. (NASDAQ:AAPL), electric vehicle maker Tesla Inc. (NASDAQ:TSLA) and oral care company SmileDirectClub Inc. (NASDAQ:SDC)."
  • Gamestop, cameco, Apple, Tesla, amc: stocks buzzing on wallstreetbets heading into new week. According to Benzinga on Monday, 13 September, "Heading into a new trading week, GameStop Corp. (NYSE:GME), Cameco Corp. (NYSE:CCJ), Apple Inc. (NASDAQ:AAPL), Tesla Inc. (NASDAQ:TSLA) and AMC Entertainment Holdings Inc. (NYSE:AMC) are among the stocks seeing the highest interest on Reddit’s r/WallStreetBets forum.", "Apart from movie theatre chain AMC Entertainment, the other stocks that are trending on the forum include Medicare Advantage provider Clover Health Investments Corp. (NASDAQ:CLOV), Canada-based cybersecurity provider BlackBerry Limited (NYSE:BB) and technology-based personal insurance company Root Inc. (NASDAQ:ROOT)."

More news about AMC.

2. JD.com (JD) – Premarket: -2.89%

NASDAQ Composite ended the session with JD.com falling 2.83% to $77.90 on Wednesday while NASDAQ Composite fell 0.45% to $15,037.76.

Volume

Today’s last reported volume for JD.com is 10490000, 15.08% below its average volume of 12353900.

JD.com’s last close was $79.86, 26.25% below its 52-week high of $108.29.

JD.com’s Sales

JD.com’s sales growth is 27.4% for the present quarter and 25.8% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 39.6% and a negative 39.1%, respectively.

JD.com’s Revenue

Year-on-year quarterly revenue growth grew by 39%, now sitting on 802.77B for the twelve trailing months.

JD.com’s Stock Yearly Top and Bottom Value

JD.com’s stock is valued at $77.90 at 08:34 EST, way below its 52-week high of $108.29 and way higher than its 52-week low of $61.65.

JD.com’s Moving Average

JD.com’s worth is above its 50-day moving average of $72.78 and higher than its 200-day moving average of $76.56.

More news about JD.com.

3. Fox Corporation (FOX) – Premarket: -2.47%

NASDAQ Composite ended the session with Fox Corporation dropping 2.64% to $32.84 on Wednesday, following the last session’s downward trend. NASDAQ Composite dropped 0.45% to $15,037.76, after five successive sessions in a row of losses, on what was a somewhat negative trend exchanging session today.

Volume

Today’s last reported volume for Fox Corporation is 856876, 17.57% below its average volume of 1039630.

Fox Corporation’s last close was $34.13, 19.01% below its 52-week high of $42.14.

Fox Corporation’s Sales

Fox Corporation’s sales growth is 5.7% for the ongoing quarter and 5.5% for the next. The company’s growth estimates for the present quarter is a negative 9.3% and positive 55.6% for the next.

Fox Corporation’s Revenue

Year-on-year quarterly revenue growth declined by 6.5%, now sitting on 12.44B for the twelve trailing months.

Fox Corporation’s Stock Yearly Top and Bottom Value

Fox Corporation’s stock is valued at $32.84 at 08:34 EST, way below its 52-week high of $42.14 and way above its 52-week low of $24.81.

Fox Corporation’s Moving Average

Fox Corporation’s value is under its 50-day moving average of $33.93 and below its 200-day moving average of $35.70.

More news about Fox Corporation.

4. Smith & Nephew (SNN) – Premarket: -2.33%

NYSE Composite ended the session with Smith & Nephew sliding 0.75% to $36.86 on Wednesday, after two successive sessions in a row of losses. NYSE Composite slid 0.42% to $16,731.05, after five successive sessions in a row of losses, on what was a somewhat down trend exchanging session today.

Volume

Today’s last reported volume for Smith & Nephew is 885071, 128.69% above its average volume of 387003.

Smith & Nephew’s last close was $38.77, 15.9% below its 52-week high of $46.10.

Smith & Nephew’s Revenue

Year-on-year quarterly revenue growth declined by 4.8%, now sitting on 4.56B for the twelve trailing months.

Smith & Nephew’s Stock Yearly Top and Bottom Value

Smith & Nephew’s stock is valued at $36.86 at 08:34 EST, way under its 52-week high of $46.10 and higher than its 52-week low of $34.29.

Smith & Nephew’s Moving Average

Smith & Nephew’s worth is below its 50-day moving average of $39.01 and under its 200-day moving average of $40.75.

More news about Smith & Nephew.

5. Lennar Corporation (LEN) – Premarket: -2.31%

NYSE Composite ended the session with Lennar Corporation sliding 0.83% to $98.59 on Wednesday while NYSE Composite slid 0.42% to $16,731.05.

Volume

Today’s last reported volume for Lennar Corporation is 1724120, 18.62% below its average volume of 2118640.

Lennar Corporation’s last close was $105.61, 4.52% below its 52-week high of $110.61.

The company’s growth estimates for the present quarter and the next is 54.7% and 59.6%, respectively.

Lennar Corporation’s Revenue

Year-on-year quarterly revenue growth grew by 21.6%, now sitting on 24.45B for the twelve trailing months.

Lennar Corporation’s Stock Yearly Top and Bottom Value

Lennar Corporation’s stock is valued at $98.59 at 08:34 EST, way below its 52-week high of $110.61 and way above its 52-week low of $69.41.

Lennar Corporation’s Moving Average

Lennar Corporation’s value is under its 50-day moving average of $105.32 and below its 200-day moving average of $99.69.

More news about Lennar Corporation.

6. Zoetis (ZTS) – Premarket: -2.24%

NYSE Composite ended the session with Zoetis falling 0.71% to $203.55 on Wednesday, after three consecutive sessions in a row of gains. NYSE Composite slid 0.42% to $16,731.05, after five sequential sessions in a row of losses, on what was a somewhat negative trend trading session today.

Volume

Today’s last reported volume for Zoetis is 1073670, 30.48% below its average volume of 1544540.

Zoetis’s last close was $209.69, 0.2% below its 52-week high of $210.10.

The company’s growth estimates for the current quarter and the next is 0.9% and 11%, respectively.

Zoetis’s Revenue

Year-on-year quarterly revenue growth grew by 25.8%, now sitting on 7.41B for the twelve trailing months.

Zoetis’s Stock Yearly Top and Bottom Value

Zoetis’s stock is valued at $203.55 at 08:34 EST, below its 52-week high of $210.10 and way above its 52-week low of $141.41.

Zoetis’s Moving Average

Zoetis’s value is under its 50-day moving average of $204.25 and way higher than its 200-day moving average of $180.54.

More news about Zoetis.

7. Pinduoduo (PDD) – Premarket: -2.04%

NASDAQ Composite ended the session with Pinduoduo dropping 2.28% to $101.78 on Wednesday while NASDAQ Composite fell 0.45% to $15,037.76.

Volume

Today’s last reported volume for Pinduoduo is 3970600, 54.26% below its average volume of 8682340.

Pinduoduo’s last close was $102.23, 51.91% under its 52-week high of $212.60.

The company’s growth estimates for the ongoing quarter is a negative 160% and positive 1350% for the next.

Pinduoduo’s Revenue

Year-on-year quarterly revenue growth grew by 89%, now sitting on 85.97B for the twelve trailing months.

Pinduoduo’s Stock Yearly Top and Bottom Value

Pinduoduo’s stock is valued at $101.78 at 08:34 EST, way under its 52-week high of $212.60 and way higher than its 52-week low of $69.89.

Pinduoduo’s Moving Average

Pinduoduo’s value is way higher than its 50-day moving average of $92.29 and way below its 200-day moving average of $121.43.

More news about Pinduoduo.

8. Fresenius Medical Care AG (FMS) – Premarket: -1.98%

NYSE Composite ended the session with Fresenius Medical Care AG falling 0.33% to $36.45 on Wednesday while NYSE Composite slid 0.42% to $16,731.05.

Volume

Today’s last reported volume for Fresenius Medical Care AG is 109312, 68.1% below its average volume of 342748.

Fresenius Medical Care AG’s last close was $38.68, 12.35% below its 52-week high of $44.13.

Fresenius Medical Care AG’s Sales

Fresenius Medical Care AG’s sales growth is a negative 5% for the current quarter and 27.6% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 26% and a negative 24.7%, respectively.

Fresenius Medical Care AG’s Revenue

Year-on-year quarterly revenue growth declined by 6.2%, now sitting on 17.58B for the twelve trailing months.

Fresenius Medical Care AG’s Stock Yearly Top and Bottom Value

Fresenius Medical Care AG’s stock is valued at $36.45 at 08:34 EST, way below its 52-week high of $44.13 and higher than its 52-week low of $33.84.

Fresenius Medical Care AG’s Moving Average

Fresenius Medical Care AG’s worth is below its 50-day moving average of $39.61 and under its 200-day moving average of $39.30.

More news about Fresenius Medical Care AG.

9. NetEase (NTES) – Premarket: -1.92%

NASDAQ Composite ended the session with NetEase dropping 4.15% to $84.52 on Wednesday, after three consecutive sessions in a row of losses. NASDAQ Composite fell 0.45% to $15,037.76, after five sequential sessions in a row of losses, on what was a somewhat negative trend exchanging session today.

Volume

Today’s last reported volume for NetEase is 5298600, 53.38% above its average volume of 3454360.

NetEase’s last close was $92.99, 30.77% below its 52-week high of $134.33.

NetEase’s Sales

NetEase’s sales growth is 13% for the current quarter and 17.5% for the next. The company’s growth estimates for the current quarter and the next is 15.9% and 188.9%, respectively.

NetEase’s Revenue

Year-on-year quarterly revenue growth grew by 12.9%, now sitting on 79.46B for the twelve trailing months.

NetEase’s Stock Yearly Top and Bottom Value

NetEase’s stock is valued at $84.52 at 08:34 EST, way under its 52-week high of $134.33 and above its 52-week low of $77.97.

NetEase’s Moving Average

NetEase’s value is below its 50-day moving average of $91.29 and way under its 200-day moving average of $104.81.

More news about NetEase.

10. Genmab (GMAB) – Premarket: -1.62%

NASDAQ Composite ended the session with Genmab sliding 0.48% to $43.81 on Wednesday, after three consecutive sessions in a row of gains. NASDAQ Composite fell 0.45% to $15,037.76, after five consecutive sessions in a row of losses, on what was a somewhat down trend trading session today.

Volume

Today’s last reported volume for Genmab is 328161, 32.74% below its average volume of 487926.

Genmab’s last close was $48.72, 0.71% under its 52-week high of $49.07.

Genmab’s Sales

Genmab’s sales growth is a negative 63.6% for the current quarter and 22.8% for the next. The company’s growth estimates for the present quarter is a negative 86.1% and positive 569.2% for the next.

Genmab’s Revenue

Year-on-year quarterly revenue growth grew by 77.2%, now sitting on 10.8B for the twelve trailing months.

Genmab’s Stock Yearly Top and Bottom Value

Genmab’s stock is valued at $43.81 at 08:34 EST, way below its 52-week high of $49.07 and way higher than its 52-week low of $30.10.

Genmab’s Moving Average

Genmab’s value is below its 50-day moving average of $46.26 and above its 200-day moving average of $40.04.

More news about Genmab.

Stay up to date with our premarket winners and losers daily report

LEAVE A REPLY

Please enter your comment!
Please enter your name here